Skip to main content

Specific PFAS Differentially Affect Maternal Midlife Adiposity

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 9, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Sept. 9, 2024 -- Specific perfluoroalkyl and polyfluoroalkyl substances (PFAS) measured in early pregnancy differentially affect maternal midlife adiposity, according to a study published online Sept. 5 in the Journal of Clinical Endocrinology & Metabolism.

Jordan A. Burdeau, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues estimated associations of early pregnancy measures of individual PFAS and PFAS mixtures with maternal adiposity in midlife in 547 Project Viva participants.

The researchers found that per doubling of perfluorooctane sulfonate (PFOS) and 2-(N-ethyl-perfluorooctane sulfonamido) acetate, linear regression estimated higher midlife weight (3.8 and 2.3 kg, respectively). A positive association was seen between PFOS and midlife adiposity (weight, 7.7 kg), trunk fat mass (1.2 kg), and total body fat mass (3.0 kg) in Bayesian Kernel Machine Regression; inverse associations were seen for perfluorononanoate and perfluorohexane sulfonate. For the overall PFAS mixture, no associations were seen.

"If our findings are supported by additional evidence, we may improve understanding of the effects of PFAS on cardiometabolic health during pregnancy, which in turn may improve early prevention or detection of adverse cardiometabolic health outcomes," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted September 2024

Read this next

Weight Reduction Varies for Patients Receiving Semaglutide, Liraglutide

FRIDAY, Sept. 13, 2024 -- For patients with obesity receiving semaglutide or liraglutide, weight reduction at one year is associated with medication active agent, dosage...

At Least One in Five People Has Obesity in Each U.S. State

THURSDAY, Sept. 12, 2024 -- Statistics from 2023 on U.S. obesity rates reveal that in every U.S. state, one in every five people now has obesity, according...

2022 Fetal Mortality Reached Historic Low of 5.48 Per 1,000

THURSDAY, Sept. 12, 2024 -- The fetal mortality rate in the United States in 2022 was 5.48 fetal deaths at 20 weeks of gestation or more per 1,000 live births and fetal deaths...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.